MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CRNX made $143,000 in revenue. -$129,518,000 in net income. Net profit margin of -90572.03%.

Income Overview

Revenue
$143,000
Net Income
-$129,518,000
Net Profit Margin
-90572.03%
EPS
-$1.38
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenues
143,000 1,031,000 361,000 259,750
Research and development
90,464,000 80,301,000 76,240,000 59,417,000
Selling, general and administrative
52,265,000 49,842,000 35,526,000 24,615,000
Total operating expenses
142,729,000 130,143,000 111,766,000 84,032,000
Loss from operations
-142,586,000 -129,112,000 -111,405,000 -83,685,666.667
Other income (expense), net
-20,000 -203,000 -160,666.667
Interest income
12,544,000 13,455,000 14,834,000 10,143,000
Other expense, net
-49,000 ---
Total other income, net
12,495,000 13,475,000 14,631,000 9,982,333.333
Loss before equity method investment
-130,091,000 115,637,000 96,774,000 73,703,333.333
Loss on equity method investment
0 ---117,500
Net loss
-130,091,000 -115,637,000 -96,774,000 -73,860,000
Unrealized gain on investment securities
594,000 -347,000 1,033,000 -747,333.333
Unrealized loss on foreign currency
-21,000 -34,000 6,000 -
Total other comprehensive income
573,000 -381,000 1,039,000 -
Comprehensive loss
-129,518,000 -116,018,000 -95,735,000 -74,607,333.333
Net loss per share - basic (in dollar per share)
-1.38 -1.23 -1.04 -0.91
Net loss per share - diluted (in dollar per share)
-1.38 -1.23 -1.04 -0.91
Weighted average shares - basic (in shares)
94,215,000 93,791,000 93,102,000 230,666.667
Weighted average shares - diluted (in shares)
94,215,000 93,791,000 93,102,000 230,666.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized gain oninvestment securities$594,000 Comprehensive loss-$129,518,000 Total othercomprehensive income$573,000 Unrealized loss on foreigncurrency-$21,000 Net loss-$130,091,000 Interest income$12,544,000 Loss before equitymethod investment-$130,091,000 Total other income,net$12,495,000 Other expense, net-$49,000 Loss from operations-$142,586,000 Revenues$143,000 Total operatingexpenses$142,729,000 Selling, general andadministrative$52,265,000 Research and development$90,464,000

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX)